These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3275779)

  • 1. Rifampicin-resistant strains of Mycobacterium leprae may have reduced virulence.
    McDermott-Lancaster RD; Hilson GR
    J Med Microbiol; 1988 Jan; 25(1):13-5. PubMed ID: 3275779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin.
    Grosset JH; Guelpa-Lauras CC; Bobin P; Brucker G; Cartel JL; Constant-Desportes M; Flageul B; Frédéric M; Guillaume JC; Millan J
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):607-14. PubMed ID: 2674301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey for secondary dapsone and rifampicin resistance in Cuba.
    González AB; Maestre JL; Hernández O; Columbié Y; Atrio N; Martin M; Fernández AM; Rodríguez J
    Lepr Rev; 1993 Jun; 64(2):128-35. PubMed ID: 8341115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of rifamycin analogues against Mycobacterium leprae.
    Dhople AM
    Indian J Lepr; 1997; 69(4):377-84. PubMed ID: 9474513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and clinical studies on rifampicin in treatment of leprosy.
    Rees RJ; Pearson JM; Waters MF
    Br Med J; 1970 Jan; 1(5688):89-92. PubMed ID: 4903972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro resistance test of human leprosy bacilli to anti-leprous drugs.
    Ishihara S; Hagiwara S; Fujuda T
    Microbios; 1977; 19(76):117-23. PubMed ID: 366337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attenuation of drug-treated murine leprous bacilli to mice. a. Examination on acid-fast bacilli isolated from the murine leprous mice administered with the drugs (in vivo), b. Examination on the drug-resistant murine leprous bacilli (in vitro) (author's transl)].
    Sushida K
    Nihon Rai Gakkai Zasshi; 1978; 47(1):13-24. PubMed ID: 359534
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
    Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular assays for determining Mycobacterium leprae viability in tissues of experimentally infected mice.
    Davis GL; Ray NA; Lahiri R; Gillis TP; Krahenbuhl JL; Williams DL; Adams LB
    PLoS Negl Trop Dis; 2013; 7(8):e2404. PubMed ID: 24179562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acid-fast bacilli isolated from foot pads of nude mice infected with leprosy bacilli].
    Mori T; Kohsaka K
    Nihon Rai Gakkai Zasshi; 1990; 59(2):113-9. PubMed ID: 2133033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
    Grosset J; Guelpa-Lauras CC; Millan J; Bodian M; Perani E
    Med Trop (Mars); 1987; 47(2):171-5. PubMed ID: 3306248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of severe combined immunodeficient mice to Mycobacterium leprae.
    Ishaque M; Sticht-Groh V; Togola D
    Microbios; 1996; 88(354):19-26. PubMed ID: 9121376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The susceptibility testing of 13 strains of Mycobacterium leprae to rifampicin and the determination of minimal effective dosage.
    Wang HY; Li WZ; Ye GY; Yu LC; Shi MQ
    Lepr Rev; 1991 Sep; 62(3):276-9. PubMed ID: 1795586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
    Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
    [No Abstract]   [Full Text] [Related]  

  • 20. Multidrug resistant Mycobacterium leprae from patients with leprosy.
    Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.